A detailed history of Cwm, LLC transactions in Scynexis Inc stock. As of the latest transaction made, Cwm, LLC holds 212 shares of SCYX stock, worth $214. This represents 0.0% of its overall portfolio holdings.

Number of Shares
212
Previous 212 -0.0%
Holding current value
$214
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

SELL
$2.38 - $3.67 $1,725 - $2,660
-725 Reduced 77.37%
212 $1,000
Q4 2022

Feb 01, 2023

SELL
$1.46 - $2.94 $963 - $1,940
-660 Reduced 41.33%
937 $1,000
Q3 2022

Oct 27, 2022

BUY
$1.83 - $2.93 $1,714 - $2,745
937 Added 141.97%
1,597 $4,000
Q2 2020

Sep 15, 2021

BUY
$7.3 - $10.2 $4,818 - $6,731
660 New
660 $5,000
Q2 2020

Jul 22, 2020

SELL
$7.3 - $10.2 $4,818 - $6,731
-660 Closed
0 $0
Q1 2020

Sep 15, 2021

BUY
$5.5 - $11.5 $3,630 - $7,590
660 New
660 $5,000
Q1 2020

Apr 28, 2020

SELL
$5.5 - $11.5 $3,630 - $7,590
-660 Closed
0 $0
Q4 2019

Sep 14, 2021

BUY
$7.24 - $13.5 $4,778 - $8,910
660 New
660 $5,000
Q4 2019

Jan 27, 2020

SELL
$7.24 - $13.5 $4,778 - $8,910
-660 Closed
0 $0
Q3 2019

Sep 14, 2021

BUY
$10.0 - $12.9 $6,600 - $8,514
660 New
660 $5,000
Q3 2019

Oct 22, 2019

SELL
$10.0 - $12.9 $6,600 - $8,514
-660 Closed
0 $0
Q2 2019

Sep 14, 2021

BUY
$10.9 - $18.5 $7,194 - $12,210
660 New
660 $5,000
Q2 2019

Jul 31, 2019

SELL
$10.9 - $18.5 $7,194 - $12,210
-660 Closed
0 $0
Q1 2019

Sep 02, 2021

BUY
$5.44 - $17.3 $3,590 - $11,418
660 New
660 $0

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $33M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.